FDA Approves Aimovig for Migraine Prevention

2020-08-17T20:59:34+00:00Industry News|

The U.S. Food and Drug Administration has approved erenumab (Aimovig™, Amgen and Novartis), a first-in-class calcitonin gene-related peptide (CGRP) antagonist, [...]